ImportantUpdates
Sai Life Sciences unveiled robust KPIs, projecting strong growth.
Sai Life Sciences LimitedSAILIFE · Filed with the exchange
Revenue is forecast to hit ₹2,192.49 Cr by Fiscal 2026, with EBITDA reaching ₹652.95 Cr (29.78% margin) and PAT at ₹348.91 Cr.
The company also anticipates significant expansion in scientific staff.
No comments yet. Be the first.